Cargando…
Fibrinolytic therapy for COVID-19: a review of case series
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661828/ https://www.ncbi.nlm.nih.gov/pubmed/34893684 http://dx.doi.org/10.1038/s41401-021-00827-w |
_version_ | 1784613391518662656 |
---|---|
author | Ji, Hong-Long Dai, Yuling Zhao, Runzhen |
author_facet | Ji, Hong-Long Dai, Yuling Zhao, Runzhen |
author_sort | Ji, Hong-Long |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8661828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-86618282021-12-10 Fibrinolytic therapy for COVID-19: a review of case series Ji, Hong-Long Dai, Yuling Zhao, Runzhen Acta Pharmacol Sin Correspondence Springer Nature Singapore 2021-12-10 2022-08 /pmc/articles/PMC8661828/ /pubmed/34893684 http://dx.doi.org/10.1038/s41401-021-00827-w Text en © The Author(s), under exclusive licence to CPS and SIMM 2021 |
spellingShingle | Correspondence Ji, Hong-Long Dai, Yuling Zhao, Runzhen Fibrinolytic therapy for COVID-19: a review of case series |
title | Fibrinolytic therapy for COVID-19: a review of case series |
title_full | Fibrinolytic therapy for COVID-19: a review of case series |
title_fullStr | Fibrinolytic therapy for COVID-19: a review of case series |
title_full_unstemmed | Fibrinolytic therapy for COVID-19: a review of case series |
title_short | Fibrinolytic therapy for COVID-19: a review of case series |
title_sort | fibrinolytic therapy for covid-19: a review of case series |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661828/ https://www.ncbi.nlm.nih.gov/pubmed/34893684 http://dx.doi.org/10.1038/s41401-021-00827-w |
work_keys_str_mv | AT jihonglong fibrinolytictherapyforcovid19areviewofcaseseries AT daiyuling fibrinolytictherapyforcovid19areviewofcaseseries AT zhaorunzhen fibrinolytictherapyforcovid19areviewofcaseseries |